内科学(神経)

研究成果

年別の研究成果 1994 2011 2012 2015 2016 2017 2018 2019 2020 2021 2022 2023 2023

• 362 Article
• 56 Review article
• 34 Letter
• 9 Comment/debate
• 6 その他
  • 3 Chapter
  • 3 Editorial

年別の研究成果

年別の研究成果

検索結果

• 2023

  A case of moyamoya disease diagnosed as cerebral infarction in the early postpregnancy period and surgically treated by bilateral revascularization after term delivery

  Takahashi, S., Katsumata, M., Mizuguchi, Y. & Toda, M., 2023 8月, In: Clinical Neurology and Neurosurgery. 231, 107859.

  研究成果: Article › 査読

  • Moyamoya Disease 100%
  • Cerebral Infarction 78%
  • Stroke 37%
  • Pregnancy 33%
  • Hospital Obstetrics and Gynecology Department 22%

• Acceleration of the Development of Microcirculation Embolism in the Brain due to Capillary Narrowing

  Murata, J., Unekawa, M., Kudo, Y., Kotani, M., Kanno, I., Izawa, Y., Tomita, Y., Tanaka, K. F., Nakahara, J. & Masamoto, K., 2023 8月 1, In: Stroke. 54, 8, p. 2135-2144 10 p.

  研究成果: Article › 査読

  • Intracranial Embolism 100%
  • Microcirculation 77%
  • Acceleration 72%
  • Capillaries 71%
  • Channelrhodopsins 45%

• Anti-N-methyl-D-aspartate receptor encephalitis with concurrent human herpes virus-6A deoxyribonucleic acid detection: An autopsy case

  Shimohama, S., Iizuka, T., Takizawa, T., Watanabe, N., Tezuka, T., Matsuda, K., Yamanoi, K., Kanazawa, N., Kawamura, Y., Yoshikawa, T., Suzuki, T., Takao, M., Nakahara, J. & Izawa, Y., 2023 6月, In: Neuropathology. 43, 3, p. 257-261 5 p.

  研究成果: Article › 査読

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis 100%
  • Autopsy 53%
  • Human Herpesvirus 6 43%
  • Viruses 42%
  • Immunotherapy 42%

• Association of immune-mediated necrotizing myopathy with HLA polymorphisms

  Ohnuki, Y., Suzuki, S., Uruha, A., Oyama, M., Suzuki, S., Kulski, J. K., Nishino, I. & Shiina, T., 2023 5月, In: HLA. 101, 5, p. 449-457 9 p.

  研究成果: Article › 査読

  • Muscular Diseases 100%
  • Myositis 32%
  • Alleles 29%
  • Autoantibodies 24%
  • Anti-Idiotypic Antibodies 22%

• Calcitonin Gene-Related Peptide mRNA Synthesis in Trigeminal Ganglion Neurons after Cortical Spreading Depolarization

  Shibata, M., Kitagawa, S., Unekawa, M., Takizawa, T. & Nakahara, J., 2023 7月, In: International journal of molecular sciences. 24, 14, 11578.

  研究成果: Article › 査読

  Open Access

  • Calcitonin Gene-Related Peptide 100%
  • Messenger RNA 59%
  • Depolarization 59%
  • Trigeminal Ganglion 54%
  • genes 49%

• Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

  Terai, H., Ishii, M., Takemura, R., Namkoong, H., Shimamoto, K., Masaki, K., Tanosaki, T., Chubachi, S., Matsuyama, E., Hayashi, R., Shimada, T., Shigematsu, L., Ito, F., Kaji, M., Takaoka, H., Kurihara, M., Nakagawara, K., Tomiyasu, S., Sasahara, K., Saito, A., & 129 othersOtake, S., Azekawa, S., Okada, M., Fukushima, T., Morita, A., Tanaka, H., Sunata, K., Asaoka, M., Nishie, M., Shinozaki, T., Ebisudani, T., Akiyama, Y., Mitsuishi, A., Nakayama, S., Ogawa, T., Sakurai, K., Irie, M., Yagi, K., Ohgino, K., Miyata, J., Kabata, H., Ikemura, S., Kamata, H., Yasuda, H., Kawada, I., Kimura, R., Kondo, M., Iwasaki, T., Ishida, N., Hiruma, G., Miyazaki, N., Ishibashi, Y., Harada, S., Fujita, T., Ito, D., Bun, S., Tabuchi, H., Kanzaki, S., Shimizu, E., Fukuda, K., Yamagami, J., Kobayashi, K., Hirano, T., Inoue, T., Haraguchi, M., Kagyo, J., Shiomi, T., Lee, H., Sugihara, K., Omori, N., Sayama, K., Otsuka, K., Miyao, N., Odani, T., Watase, M., Mochimaru, T., Satomi, R., Oyamada, Y., Masuzawa, K., Asakura, T., Nakayama, S., Suzuki, Y., Baba, R., Okamori, S., Arai, D., Nakachi, I., Kuwahara, N., Fujiwara, A., Oakada, T., Ishiguro, T., Isosno, T., Makino, Y., Mashimo, S., Kaido, T., Minematsu, N., Ueda, S., Minami, K., Hagiwara, R., Manabe, T., Fukui, T., Funatsu, Y., Koh, H., Yoshiyama, T., Kokuto, H., Kusumoto, T., Oashi, A., Miyawaki, M., Saito, F., Tani, T., Ishioka, K., Takahashi, S., Nakamura, M., Harada, N., Sasano, H., Goto, A., Kusaka, Y., Ohba, T., Nakano, Y., Nishio, K., Nakajima, Y., Suzuki, S., Yoshida, S., Tateno, H., Kodama, N., Shunsuke, M., Sakamoto, S., Okamoto, M., Nagasaki, Y., Umeda, A., Miyagawa, K., Shimada, H., Hagimura, K., Nagashima, K., Sato, T., Sato, Y., Hasegawa, N., Takebayashi, T., Nakahara, J., Mimura, M., Ogawa, K., Shimmura, S., Negishi, K., Tsubota, K., Amagai, M., Goto, R., Ibuka, Y., Kitagawa, Y., Kanai, T. & Fukunaga, K., 2023 11月, In: Respiratory Investigation. 61, 6, p. 802-814 13 p.

  研究成果: Article › 査読

  • Cohort Studies 100%
  • Prospective Studies 93%
  • Patient Reported Outcome Measures 46%
  • Medical Records 34%
  • Hospitalization 30%
  1 被引用数 (Scopus)

• COVID-19 vaccination elicited de novo and recurrence of cluster headache: A case series

  Chen, S. P., Takizawa, T., Sekiguchi, K., Nakahara, J. & Wang, S. J., 2023 5月, In: Cephalalgia. 43, 5

  研究成果: Article › 査読

  Open Access

  • Cluster Headache 100%
  • Coronavirus 91%
  • Vaccination 58%
  • Recurrence 41%
  • Vaccines 32%

• Dysautonomia associated with immune checkpoint inhibitors

  Tezuka, T., Okuzumi, S., Nakashima, C., Ide, T., Imai, S., Mitsuboshi, S., Kuwahara, Y., Takizawa, T., Seki, M., Minematsu, N., Aragane, N., Nakahara, J., Hori, S., Nakane, S. & Suzuki, S., 2023 7月, In: Journal of Neurology. 270, 7, p. 3413-3423 11 p.

  研究成果: Article › 査読

  • Primary Dysautonomias 100%
  • Ipilimumab 23%
  • Pharmacovigilance 22%
  • Hashimoto's encephalitis 12%
  • Nivolumab 11%
  1 被引用数 (Scopus)

• Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis

  Uzawa, A., Suzuki, S., Kuwabara, S., Akamine, H., Onishi, Y., Yasuda, M., Ozawa, Y., Kawaguchi, N., Kubota, T., Takahashi, M. P., Suzuki, Y., Watanabe, G., Kimura, T., Sugimoto, T., Samukawa, M., Minami, N., Masuda, M., Konno, S., Nagane, Y. & Utsugisawa, K., 2023 6月 1, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 467-473 7 p.

  研究成果: Article › 査読

  • Myasthenia Gravis 100%
  • Calcineurin Inhibitors 15%
  • Therapeutics 14%
  • Methylprednisolone 13%
  • Immunotherapy 10%
  4 被引用数 (Scopus)

• Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review

  Caronna, E., van den Hoek, T. C., Bolay, H., Garcia-Azorin, D., Gago-Veiga, A. B., Valeriani, M., Takizawa, T., Messlinger, K., Shapiro, R. E., Goadsby, P. J., Ashina, M., Tassorelli, C., Diener, H. C., Terwindt, G. M. & Pozo-Rosich, P., 2023 1月, In: Cephalalgia. 43, 1

  研究成果: Review article › 査読

  Open Access

  • SARS Virus 100%
  • Primary Headache Disorders 96%
  • Pandemics 72%
  • Headache 58%
  • Vaccination 54%
  10 被引用数 (Scopus)

• Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management

  Shimohama, S., Tezuka, T., Takahata, K., Bun, S., Tabuchi, H., Seki, M., Momota, Y., Suzuki, N., Morimoto, A., Iwabuchi, Y., Kubota, M., Yamamoto, Y., Sano, Y., Shikimoto, R., Funaki, K., Mimura, Y., Nishimoto, Y., Ueda, R., Jinzaki, M., Nakahara, J., & 2 othersMimura, M. & Ito, D., 2023 1月 17, In: Neurology. 100, 3, p. E264-E274

  研究成果: Article › 査読

  • Amyloid 100%
  • Dementia 88%
  • Cognitive Dysfunction 57%
  • 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 21%
  • Change Management 17%
  7 被引用数 (Scopus)

• Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis

  Uzawa, A., Suzuki, S., Kuwabara, S., Akamine, H., Onishi, Y., Yasuda, M., Ozawa, Y., Kawaguchi, N., Kubota, T., Takahashi, M. P., Suzuki, Y., Watanabe, G., Kimura, T., Sugimoto, T., Samukawa, M., Minami, N., Masuda, M., Konno, S., Nagane, Y. & Utsugisawa, K., 2023 3月, In: Neurotherapeutics. 20, 2, p. 518-523 6 p.

  研究成果: Article › 査読

  • Myasthenia Gravis 100%
  • Methylprednisolone 96%
  • Immunotherapy 28%
  • Prednisolone 22%
  • Therapeutics 14%

• Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

  Imai, S., Mitsuboshi, S., Hori, S. & Suzuki, S., 2023 2月, In: European Journal of Cancer. 180, p. 1-3 3 p.

  研究成果: Letter › 査読
  3 被引用数 (Scopus)

• Japan MG registry: Chronological surveys over 10 years

  Suzuki, S., Masuda, M., Uzawa, A., Nagane, Y., Konno, S., Suzuki, Y., Kubota, T., Sugimoto, T., Samukawa, M., Watanabe, G., Ishizuchi, K., Akamine, H., Onishi, Y., Yoshizumi, K., Uchi, T., Amino, I., Ueta, Y., Minami, N., Kawaguchi, N., Kimura, T., & 3 othersTakahashi, M. P., Murai, H. & Utsugisawa, K., 2023 2月, In: Clinical and Experimental Neuroimmunology. 14, 1, p. 5-12 8 p.

  研究成果: Review article › 査読

  Open Access

  • Japan 100%
  • Registries 95%
  • Prednisolone 82%
  • Myasthenia Gravis 46%
  • Quality of Life 25%
  8 被引用数 (Scopus)

• Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks

  Begasse de Dhaem, O., Takizawa, T. & Dodick, D. W., 2023 2月, In: Cephalalgia. 43, 2

  研究成果: Review article › 査読

  Open Access

  • (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate 100%
  • ubrogepant 97%
  • lasmiditan 93%
  • Migraine Disorders 47%
  • Aspartate Aminotransferases 28%
  4 被引用数 (Scopus)

• Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan

  Nakashima, I., Nakahara, J., Yokote, H., Manabe, Y., Okamura, K., Hasegawa, K. & Fujihara, K., 2023 1月 1, In: Therapeutic Advances in Neurological Disorders. 16

  研究成果: Article › 査読

  Open Access

  • eculizumab 100%
  • Aquaporin 4 89%
  • Neuromyelitis Optica 89%
  • Marketing 71%
  • Japan 54%
  1 被引用数 (Scopus)

• Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis

  Ito, D., Morimoto, S., Takahashi, S., Okada, K., Nakahara, J. & Okano, H., 2023 1月 1, In: Brain. 146, 1, p. 13-19 7 p.

  研究成果: Review article › 査読

  Open Access

  • ezogabine 100%
  • ropinirole 95%
  • Preclinical Drug Evaluations 71%
  • Induced Pluripotent Stem Cells 68%
  • bosutinib 67%
  4 被引用数 (Scopus)

• Migraine triggers in Asian countries: a narrative review

  Iba, C., Ohtani, S., Lee, M. J., Huh, S., Watanabe, N., Nakahara, J., Peng, K. P. & Takizawa, T., 2023, In: Frontiers in Neurology. 14, 1169795.

  研究成果: Review article › 査読

  Open Access

  • Migraine Disorders 100%
  • Weather 30%
  • Sleep 28%
  • Feeding Behavior 24%
  • Western Asia 21%
  3 被引用数 (Scopus)

• Muscle pathology of antisynthetase syndrome according to antibody subtypes

  Tanboon, J., Inoue, M., Hirakawa, S., Tachimori, H., Hayashi, S., Noguchi, S., Okiyama, N., Fujimoto, M., Suzuki, S. & Nishino, I., 2023 7月, In: Brain Pathology. 33, 4, e13155.

  研究成果: Article › 査読

  Open Access

  • Antisynthetase syndrome 100%
  • HLA-DR Antigens 41%
  • Pathology 36%
  • Muscles 34%
  • Antibodies 31%
  1 被引用数 (Scopus)

• Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011–2020

  Nakamichi, K., Miura, Y., Shimokawa, T., Takahashi, K., Suzuki, T., Funata, N., Harada, M., Mori, K., Sanjo, N., Yukitake, M., Takahashi, K., Hamaguchi, T., Izaki, S., Oji, S., Nakahara, J., Ae, R., Kosami, K., Nukuzuma, S., Nakamura, Y., Nomura, K., & 6 othersKishida, S., Mizusawa, H., Yamada, M., Takao, M., Ebihara, H. & Saijo, M., 2023 4月, In: Viruses. 15, 4, 968.

  研究成果: Article › 査読

  Open Access

  • Progressive Multifocal Leukoencephalopathy 100%
  • JC Virus 67%
  • Japan 60%
  • Cerebrospinal Fluid 35%
  • Polymerase Chain Reaction 14%
  4 被引用数 (Scopus)

• Overlap syndrome with antibodies against multiple transfer-RNA components presenting antisynthetase syndrome

  Motegi, H., Kirino, Y., Morishita, R., Nishino, I. & Suzuki, S., 2023 5月, In: Neuromuscular Disorders. 33, 5, p. 405-409 5 p.

  研究成果: Article › 査読

  • Antisynthetase syndrome 100%
  • Transfer RNA 62%
  • Antibodies 31%
  • Myositis 28%
  • Systemic Scleroderma 26%

• Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery

  The Pooled Resource Open-Access ALS Clinical Trials Consortium, 2023 6月 1, In: Cell stem cell. 30, 6, p. 766-780.e9

  研究成果: Article › 査読

  Open Access

  • ropinirole 100%
  • Clinical Trials, Phase I 76%
  • Drug Discovery 65%
  • Therapeutic Uses 34%
  • Disease Progression 33%
  3 被引用数 (Scopus)

• Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study

  Ihara, K., Ohtani, S., Watanabe, N., Takahashi, N., Miyazaki, N., Ishizuchi, K., Hori, S., Takemura, R., Nakahara, J. & Takizawa, T., 2023 12月, In: Journal of Headache and Pain. 24, 1, 23.

  研究成果: Article › 査読

  Open Access

  • Migraine Disorders 100%
  • Japan 82%
  • Observational Studies 77%
  • Monoclonal Antibodies 72%
  • Calcitonin Gene-Related Peptide 69%
  10 被引用数 (Scopus)

• Prescribing patterns and determinants for elderly patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databases

  Seki, M., Kawata, Y., Hayashi, A., Arai, M. & Fujimoto, S., 2023, In: Frontiers in Neurology. 14, 1162016.

  研究成果: Article › 査読

  Open Access

  • Levodopa 100%
  • Insurance 91%
  • Parkinson Disease 75%
  • Japan 74%
  • Observational Studies 69%
  1 被引用数 (Scopus)

• Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis

  Mori, S., Suzuki, S., Konishi, T., Kawaguchi, N., Kishi, M., Kuwabara, S., Ishizuchi, K., Zhou, H., Shibasaki, F., Tsumoto, H., Omura, T., Miura, Y., Mori, S., Higashihara, M., Murayama, S. & Shigemoto, K., 2023 3月, In: Experimental Neurology. 361, 114300.

  研究成果: Article › 査読

  Open Access

  • Myasthenia Gravis 100%
  • Protein-Tyrosine Kinases 78%
  • Muscles 51%
  • Neuromuscular Junction 40%
  • Denervation 18%

• Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study

  Ohtani, S., Watanabe, N., Ihara, K., Takahashi, N., Miyazaki, N., Ishizuchi, K., Takemura, R., Hori, S., Nakahara, J. & Takizawa, T., 2023 12月, In: BMC Neurology. 23, 1, 404.

  研究成果: Article › 査読

  Open Access

  • fremanezumab 100%
  • Migraine Disorders 51%
  • Japan 42%
  • Injection Site Reaction 35%
  • Retrospective Studies 34%

• Reversible Splenial Lesion Triggered by Hyperthyroidism

  Okusa, S., Nakahara, J. & Takizawa, T., 2023, In: Internal Medicine. 62, 19, p. 2925-2926 2 p.

  研究成果: Article › 査読

  Open Access

• Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry

  Shiozawa, M., Koga, M., Inoue, H., Yamashita, T., Yasaka, M., Suzuki, S., Akao, M., Atarashi, H., Ikeda, T., Okumura, K., Koretsune, Y., Shimizu, W., Tsutsui, H., Hirayama, A., Nakahara, J., Teramukai, S., Kimura, T., Morishima, Y., Takita, A., Yamaguchi, T., & 1 othersToyoda, K., 2023 10月, In: International Journal of Stroke. 18, 8, p. 986-995 10 p.

  研究成果: Article › 査読

  Open Access

  • Intracranial Hemorrhages 100%
  • Warfarin 93%
  • Anticoagulants 81%
  • Atrial Fibrillation 78%
  • Registries 70%

• Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

  MG0003 study team, 2023 5月, In: The Lancet Neurology. 22, 5, p. 383-394 12 p.

  研究成果: Article › 査読

  • rozanolixizumab 100%
  • Myasthenia Gravis 49%
  • Placebos 29%
  • Safety 24%
  • neonatal Fc receptors 8%
  14 被引用数 (Scopus)

• Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

  RAISE Study Team, 2023 5月, In: The Lancet Neurology. 22, 5, p. 395-406 12 p.

  研究成果: Article › 査読

  • Myasthenia Gravis 100%
  • Placebos 59%
  • Safety 50%
  • Activities of Daily Living 30%
  • Cholinergic Receptors 25%
  13 被引用数 (Scopus)

• Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosing

  Ihara, K., Ohtani, S., Watanabe, N., Takahashi, N., Miyazaki, N., Takemura, R., Hori, S., Nakahara, J. & Takizawa, T., 2023 10月 15, In: Journal of the Neurological Sciences. 453, 120811.

  研究成果: Article › 査読

  Open Access

  • fremanezumab 100%
  • Calcitonin Gene-Related Peptide 75%
  • galcanezumab 74%
  • Migraine Disorders 64%
  • Monoclonal Antibodies 46%

• The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome

  Murai, H., Utsugisawa, K., Motomura, M., Imai, T., Uzawa, A. & Suzuki, S., 2023 2月, In: Clinical and Experimental Neuroimmunology. 14, 1, p. 19-27 9 p.

  研究成果: Review article › 査読

  Open Access

  • Myasthenia Gravis 100%
  • Muscle Weakness 91%
  • Guidelines 55%
  • Appointments and Schedules 9%
  • Steroids 9%
  6 被引用数 (Scopus)

• “Missing-piece” sign with dural arteriovenous fistula at craniocervical junction: A case report

  Tezuka, T., Nukariya, T., Katsumata, M., Miyauchi, T., Tokuyasu, D., Azami, S., Izawa, Y., Nagoshi, N., Fujiwara, H., Mizutani, K., Akiyama, T., Toda, M., Nakahara, J. & Nishimoto, Y., 2023 7月, In: Journal of Stroke and Cerebrovascular Diseases. 32, 7, 107152.

  研究成果: Article › 査読

  • Central Nervous System Vascular Malformations 100%
  • Early Diagnosis 19%
  • Spinal Diseases 17%
  • Medulla Oblongata 14%
  • Blood Vessels 14%
  1 被引用数 (Scopus)
• 2022

  A Comparison of Line Blots, Enzyme-linked Immunosorbent, and RNA-immunoprecipitation Assays of Antisynthetase Antibodies in Serum Samples from 44 Patients

  Shinoda, K., Okumura, M., Yamaguchi, S., Matsui, A., Tsuda, R., Hounoki, H., Suzuki, S. & Tobe, K., 2022, In: Internal Medicine. 61, 3, p. 313-322 10 p.

  研究成果: Article › 査読

  Open Access

  • Amino Acyl-tRNA Synthetases 100%
  • Immunosorbents 93%
  • Immunoprecipitation 70%
  • Antisynthetase syndrome 62%
  • RNA 50%
  2 被引用数 (Scopus)

• Anemia in female patients with myasthenia gravis

  Sekiguchi, K., Ishizuchi, K., Takizawa, T., Motegi, H., Oyama, M., Nakahara, J. & Suzuki, S., 2022 9月, In: PloS one. 17, 9 September, e0273720.

  研究成果: Article › 査読

  Open Access

  • Myasthenia Gravis 100%
  • Anemia 72%
  • Immunosuppressive Agents 11%
  • Quality of Life 8%
  • Calcineurin Inhibitors 8%
  2 被引用数 (Scopus)

• Association between multimorbidity, self-rated health and life satisfaction among independent, community-dwelling very old persons in Japan: longitudinal cohort analysis from the Kawasaki Ageing and Well-being Project

  Ando, T., Nishimoto, Y., Hirata, T., Abe, Y., Takayama, M., Maeno, T., Fujishima, S., Takebayashi, T. & Arai, Y., 2022 2月 24, In: BMJ open. 12, 2, e049262.

  研究成果: Article › 査読

  Open Access

  • Multimorbidity 100%
  • Independent Living 76%
  • Japan 61%
  • Cohort Studies 50%
  • Health 36%
  7 被引用数 (Scopus)

• Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET

  Momota, Y., Konishi, M., Takahata, K., Kishimoto, T., Tezuka, T., Bun, S., Tabuchi, H., Ito, D. & Mimura, M., 2022 11月 15, In: Frontiers in Neurology. 13, 1049113.

  研究成果: Article › 査読

  Open Access

  • Primary Progressive Aphasia 100%
  • Tauopathies 89%
  • Amyloid 62%
  • Positron-Emission Tomography 61%
  • Alzheimer Disease 51%

• Close association between spreading depolarization and development of infarction under experimental ischemia in anesthetized male mice

  Unekawa, M., Tomita, Y., Masamoto, K., Kanno, I., Nakahara, J. & Izawa, Y., 2022 10月 1, In: Brain Research. 1792, 148023.

  研究成果: Article › 査読

  Open Access

  • Cerebrovascular Circulation 100%
  • Infarction 86%
  • Ischemia 78%
  • Middle Cerebral Artery Infarction 28%
  • Parietal Bone 18%
  1 被引用数 (Scopus)

• Dermatomyositis-like rash and inflammatory myopathy after mRNA-1273 vaccination

  Kondo, Y., Oyama, M., Nakamura, Y., Matsubara, S., Tanikawa, A. & Kaneko, Y., 2022 7月 1, In: Revmatologiia (Bulgaria). 61, 7, p. E171-E173

  研究成果: Article › 査読
  6 被引用数 (Scopus)

• Effect of Goreisan, a Japanese Traditional Medicine, on Cortical Spreading Depolarization in Mice

  Iba, C., Unekawa, M., Izawa, Y., Nakahara, J. & Takizawa, T., 2022 11月, In: International journal of molecular sciences. 23, 22, 13803.

  研究成果: Article › 査読

  Open Access

  • Depolarization 100%
  • medicine 76%
  • Traditional Medicine 75%
  • Spreading 75%
  • mice 74%
  1 被引用数 (Scopus)

• Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study

  Kira, J. I., Nakahara, J., Sazonov, D. V., Kurosawa, T., Tsumiyama, I., Willi, R., Zalesak, M., Pingili, R., Häring, D. A., Ramanathan, K., Kieseier, B. C., Merschhemke, M., Su, W. & Saida, T., 2022 7月, In: Multiple Sclerosis Journal. 28, 8, p. 1229-1238 10 p.

  研究成果: Article › 査読

  • ofatumumab 100%
  • Russia 70%
  • Multiple Sclerosis 52%
  • Japan 49%
  • Placebos 41%
  10 被引用数 (Scopus)

• Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective

  Suzuki, S., Uzawa, A. & Murai, H., 2022, In: Expert Review of Clinical Immunology. 18, 12, p. 1207-1215 9 p.

  研究成果: Article › 査読

  • Myasthenia Gravis 100%
  • Cholinergic Receptors 94%
  • Antibodies 47%
  • Biological Products 24%
  • Japan 20%
  1 被引用数 (Scopus)

• Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study

  Hatano, T., Kano, O., Sengoku, R., Yoritaka, A., Suzuki, K., Nishikawa, N., Mukai, Y., Nomura, K., Yoshida, N., Seki, M., Matsukawa, M. K., Terashi, H., Kimura, K., Tashiro, J., Hirano, S., Murakami, H., Joki, H., Uchiyama, T., Shimura, H., Ogaki, K., & 6 othersFukae, J., Tsuboi, Y., Takahashi, K., Yamamoto, T., Yanagisawa, N. & Nagayama, H., 2022 12月, In: BMC Neurology. 22, 1, 71.

  研究成果: Article › 査読

  Open Access

  • istradefylline 100%
  • Levodopa 60%
  • Parkinson Disease 45%
  • Japan 6%
  • Secondary Parkinson Disease 6%
  3 被引用数 (Scopus)

• Findings of ¹⁸F-PI-2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample

  Bun, S., Moriguchi, S., Tezuka, T., Sato, Y., Takahata, K., Seki, M., Nakajima, S., Yamamoto, Y., Sano, Y., Suzuki, N., Morimoto, A., Ueda, R., Tabuchi, H., Ito, D. & Mimura, M., 2022 12月, In: Neuropsychopharmacology Reports. 42, 4, p. 437-448 12 p.

  研究成果: Article › 査読

  Open Access

  • dementia 100%
  • Alzheimer Disease 77%
  • brain 16%
  • Neocortex 12%
  • cognitive impairment 12%
  2 被引用数 (Scopus)

• Flare of myasthenia gravis induced by COVID-19 vaccines

  Ishizuchi, K., Takizawa, T., Sekiguchi, K., Motegi, H., Oyama, M., Nakahara, J. & Suzuki, S., 2022 5月 15, In: Journal of the Neurological Sciences. 436, 120225.

  研究成果: Letter › 査読
  21 被引用数 (Scopus)

• Immunodeficiency in patients with thymoma-associated myasthenia gravis

  Ishizuchi, K., Takizawa, T., Ohnuki, Y., Sekiguchi, K., Motegi, H., Oyama, M., Nakahara, J., Shiina, T. & Suzuki, S., 2022 10月 15, In: Journal of Neuroimmunology. 371, 577950.

  研究成果: Article › 査読

  • Thymoma 100%
  • Myasthenia Gravis 96%
  • Pneumonia 16%
  • Immunoglobulin G 15%
  • Alleles 15%

• Immunohistochemical Phenotype of T Cells Invading Muscle in Inclusion Body Myositis

  Matsubara, S., Suzuki, S. & Komori, T., 2022 10月 1, In: Journal of Neuropathology and Experimental Neurology. 81, 10, p. 825-835 11 p.

  研究成果: Article › 査読

  • Inclusion Body Myositis 100%
  • T-Lymphocytes 41%
  • Muscles 40%
  • Phenotype 40%
  • Lymphocytes 12%
  4 被引用数 (Scopus)

• Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study

  Sekiguchi, K., Watanabe, N., Miyazaki, N., Ishizuchi, K., Iba, C., Tagashira, Y., Uno, S., Shibata, M., Hasegawa, N., Takemura, R., Nakahara, J. & Takizawa, T., 2022 3月, In: Cephalalgia. 42, 3, p. 266-272 7 p.

  研究成果: Article › 査読

  Open Access

  • Headache 100%
  • Vaccination 93%
  • Cross-Sectional Studies 76%
  • Incidence 56%
  • Migraine Disorders 27%
  25 被引用数 (Scopus)

• Influence of a clinical trial in the decision-making processes of patients with amyotrophic lateral sclerosis

  Kato, C., Morimoto, S., Takahashi, S., Date, Y., Okada, K., Okano, H., Nakahara, J. & Ito, D., 2022 5月, In: Journal of Neurology. 269, 5, p. 2634-2640 7 p.

  研究成果: Article › 査読

  • Amyotrophic Lateral Sclerosis 100%
  • Decision Making 76%
  • Clinical Trials 60%
  • Tracheostomy 53%
  • Ventilation 41%

• Intracerebral hemorrhage and thrombin-induced alterations in cerebral microvessel matrix

  Gu, Y. H., Hawkins, B. T., Izawa, Y., Yoshikawa, Y., Koziol, J. A. & del Zoppo, G. J., 2022 9月, In: Journal of Cerebral Blood Flow and Metabolism. 42, 9, p. 1732-1747 16 p.

  研究成果: Article › 査読

  • Cerebral Hemorrhage 100%
  • Microvessels 93%
  • Thrombin 91%
  • Dabigatran 24%
  • Permeability 15%
  2 被引用数 (Scopus)